Insulin allergy and extensive lipoatrophy in child with type 1 diabetes

Hormone Research

Volumn 65, Issue 5, 2006, Pages 253-260

  Beltrand, Jacques ^a   Guilmin Crepon, Sophie ^b   Castanet, Mireille ^b   Peuchmaur, Michel ^b,c   Czernichow, Paul ^b   Levy Marchal, Claire ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Insulin allergy; Lipoatrophy; Pump therapy; Type 1 diabetes

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; ISOPHANE INSULIN; METHOTREXATE; RECOMBINANT HUMAN INSULIN; STEROID;

ARTICLE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILY HISTORY; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPOATROPHY; MALE; ONSET AGE; PATHOPHYSIOLOGY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; TREATMENT OUTCOME;

CHILD; DIABETES MELLITUS, TYPE 1; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPODYSTROPHY; MALE; PEDIGREE;

EID: 33646118250     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092515     Document Type: Article

References (25)

1. Naf S, Esmatjes E, Recasens M, Valero A, Halperin I, Levy I, Gomis R: Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care 2002;25:634-635.
2. Eapen SS, Connor EL, Gern JE: Insulin desensitization with insulin lispro and an insulin pump in a 5-year old child. Ann Allergy Asthma Immunol 2000;85:395-397.
3. Kumar D: Lispro analogue for the treatment of generalized allergy to human insulin. Diabetes care 1997;20:1357-1359.
4. Nagai Y, Mori T, Abe T, Nomura G: Immediate-type allergy against human insulin associated with marked eosinophilia in type 2 diabetic patient. Endocr J 2001;48:311-316.
5. Reeves WG, Allen BR, Tattersall RB: Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 1980;280:1500-1503.
6. Takatsuki H, Ishii H, Yamauchi T, Nakashima N, Nagase S, Hisatomi A, Umeda F, Nawata H: A case of insulin allergy: the crystalline human insulin may mask its antigenicity. Diabetes Res Clin Pract 1991;12:137-139.
7. Atlan-Gepner C, Bongrand P, Farnarier C, Xerri L, Choux R, Gauthier JF, Brue T, Vague P, Grob JJ, Vialettes B: Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care 1996;19:1283-1285.
8. Jermendy G, Nadas J, Sapi Z: 'Lipoblastoma-like' lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes? Diabetologia 2000;43:955-956.
9. Sola-Gazagnes A, Pecquet C, Radermecker R, Pietri L, Elgrably F, Slama G, Selam JL: Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care 2003;26:2961-2962.
10. Griffin ME, Feder A, Tamborlane WV: Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care 2001;24:174.
11. Ampudia-Blasco FJ, Hasbum B, Carmena R: A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications? Diabetes Care 2003;26:953-954.
12. Reeves WG, Allen BR, Tattersall RB: Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 1980;280:1500-1503.
13. Petruschke T, Hauner H: Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 1993;76:742-747.
14. Kudo M, Sugawara A, Uruno A, Takeuchi K, Ito S: Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology 2004;145:4948-4956.
15. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, Luboinski J, Laville M, Maachi M, Girard PM, Rozenbaum W, Levan P, Capeau J: Association between altered expression of adipogenic factor SREBP1 inlipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002;359:1026-1031.
16. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV: Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004;76:707-726.
17. Cambronero R, Sewell WA, North ME, Webster AD, Farrant J: Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 2000;164:488-494.
18. North ME, Webster AD, Farrant J: Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets. Clin Exp Immunol 1998;111:70-75.
19. Barton JC, Bertoli LF, Acton RT: HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama. BMC Med Genet 2003;12;4:3.
20. Metin A, Tezcan I, Ozyurek H: IDDM in an adolescent patient with common variable immunodeficiency. Diabetes Care 1997;20:677-678.
21. Conley ME, Park CL, Douglas SD: Childhood common variable immunodeficiency with autoimmune disease. J Pediatr 1986;108:915-922.
22. Iglesias P, Ferreira A, Diez JJ: Common variable immunodeficiency in adult woman with IDDM. Diabetes Care 1998;21:1029.
23. Johnston SL, Virgo PF, Unsworth DJ: Type 1 diabetes mellitus masking primary antibody deficiency. J Clin Pathol 2000;53:236-237.
24. Arranz A, Andia V, Lopez-Guzman A: A case of lipoatrophy with lispro insulin without insulin pump therapy. Diabetes Care 2004;27:625-626.
25. Airaghi L, Lorini M, Tedeschi A: The insulin analog as part: a safe alternative in insulin allergy. Diabetes Care 2001;24:2000.